Process Development of Amlodipine and Olmesartan Medoxomil Tablets

Process Development of Amlodipine and Olmesartan Medoxomil Tablets

EnglishPaperback / softback
Behera, Gayatri
LAP Lambert Academic Publishing
EAN: 9786203409338
On order
Delivery on Friday, 20. of December 2024
€62.26
Common price €69.18
Discount 10%
pc
Do you want this product today?
Oxford Bookshop Banská Bystrica
not available
Oxford Bookshop Bratislava
not available
Oxford Bookshop Košice
not available

Detailed information

The present study was focused on process development of amlodipine and olmesartan medoxomil tablet 10/40mg. Amlodipine and Olmesartan medoxomil is a combination of a calcium channel blocker and an angiotensin II receptor antagonist used to treat high blood pressure . The Content uniformity was found of both the drugs were performed. Release study was conducted in pH 6.8 buffer media. Furthermore, dissolution profile comparison was carried out using similarity factor (f2) and the similarity factor of Amlodipine and Olmesartan Medoxomil found to be 73. Other studies Like DSC and FTIR studies reported compatibility of Amlodipine besylate with excipients like Cross Carmel lose sodium was performed shows no chemical interaction between drug and excipients. Dissolution profile of Test and Reference standard found to be similar, Similarity factor (f2) is 73.
EAN 9786203409338
ISBN 6203409332
Binding Paperback / softback
Publisher LAP Lambert Academic Publishing
Publication date February 8, 2021
Pages 72
Language English
Dimensions 229 x 152 x 4
Readership General
Authors Barik, Binapani; Behera, Gayatri; Behera, Jayashree